Literature DB >> 17525531

Differential repression of c-myc and cdc2 gene expression by ERF and PE-1/METS.

Kelly D Hester1, Dominique Verhelle, Laure Escoubet-Lozach, Rosa Luna, David W Rose, Christopher K Glass.   

Abstract

The molecular mechanisms that control the proliferation and differentiation of specific cell types remain poorly understood. Positive ETS factors play important roles in mediating proliferative responses to Ras/MAPK signaling in many cell types following mitogenic stimulation. PE-1/METS, a member of the ETS-domain family transcription factors that functions as a transcriptional repressor, can block mitogenic responses mediated by positively acting Ets factors. The anti-proliferative functions of PE-1/METS require its interaction with DP103, a multifunctional DEAD-box protein that mediates interactions with corepressor proteins and acts in a cooperative manner with Rb family members and to repress cell cycle control genes. ETS-2 repressor factor (ERF) is structurally related to and also functions as a transcriptional repressor, but endogenous target genes and mechanisms of repression remain unknown. Here, we demonstrate that like PE-1/METS, ERF-mediated repression also requires DP103, and that ERF negatively regulates the c-myc and cdc2 genes. In contrast to PE-1/METS, however, ERF-mediated repression of these genes is inactivated by MAPK signaling through phosphorylation sites that are ERF-specific. Furthermore, constitutive activation of the Ras/MAPK pathway in RAW 264.7 cells transformed by the v-Abelson leukemia virus is associated with constitutive inactivation of ERF in this cell type. We propose that ERF and PE-1/METS function to impose 'repression checkpoints' on a subset of cell cycle control genes that are differentially regulated by growth factor signaling pathways that control proliferation and differentiation and that ERF is targeted for inactivation by transforming oncogenes such as vAbl.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17525531     DOI: 10.4161/cc.6.13.4336

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  9 in total

1.  Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways.

Authors:  Serena Ghisletti; Wendy Huang; Kristen Jepsen; Chris Benner; Gary Hardiman; Michael G Rosenfeld; Christopher K Glass
Journal:  Genes Dev       Date:  2009-03-15       Impact factor: 11.361

2.  Genome-wide profiling of in vivo LPS-responsive genes in splenic myeloid cells.

Authors:  Myeong Sup Lee; Byungil Kim; Sun-Min Lee; Woo-Cheul Cho; Wook-Bin Lee; Ji-Seon Kang; Un Yung Choi; Jaemyun Lyu; Young-Joon Kim
Journal:  Mol Cells       Date:  2013-05-10       Impact factor: 5.034

Review 3.  Retinoic acid signaling and neuronal differentiation.

Authors:  Amanda Janesick; Stephanie Cherie Wu; Bruce Blumberg
Journal:  Cell Mol Life Sci       Date:  2015-01-06       Impact factor: 9.261

4.  Large-scale discovery of ERK2 substrates identifies ERK-mediated transcriptional regulation by ETV3.

Authors:  Scott M Carlson; Candace R Chouinard; Adam Labadorf; Carol J Lam; Katrin Schmelzle; Ernest Fraenkel; Forest M White
Journal:  Sci Signal       Date:  2011-10-25       Impact factor: 8.192

5.  DEAD-box protein-103 (DP103, Ddx20) is essential for early embryonic development and modulates ovarian morphology and function.

Authors:  Jean-François Mouillet; Xiaomei Yan; Qinglin Ou; Lingling Jin; Louis J Muglia; Peter A Crawford; Yoel Sadovsky
Journal:  Endocrinology       Date:  2008-02-07       Impact factor: 4.736

6.  Structural Insight into the DNA Binding Function of Transcription Factor ERF.

Authors:  Caixia Hou; Claudia McCown; Dmitri N Ivanov; Oleg V Tsodikov
Journal:  Biochemistry       Date:  2020-11-11       Impact factor: 3.162

7.  Survey of activated FLT3 signaling in leukemia.

Authors:  Ting-lei Gu; Julie Nardone; Yi Wang; Marc Loriaux; Judit Villén; Sean Beausoleil; Meghan Tucker; Jon Kornhauser; Jianmin Ren; Joan MacNeill; Steven P Gygi; Brian J Druker; Michael C Heinrich; John Rush; Roberto D Polakiewicz
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

8.  Neural stem and progenitor cells shorten S-phase on commitment to neuron production.

Authors:  Yoko Arai; Jeremy N Pulvers; Christiane Haffner; Britta Schilling; Ina Nüsslein; Federico Calegari; Wieland B Huttner
Journal:  Nat Commun       Date:  2011-01-11       Impact factor: 14.919

9.  Matrine inhibits BCR/ABL mediated ERK/MAPK pathway in human leukemia cells.

Authors:  Lingdi Ma; Zhenyu Xu; Jian Wang; Zhichao Zhu; Guibin Lin; Lijia Jiang; Xuzhang Lu; Chang Zou
Journal:  Oncotarget       Date:  2017-11-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.